Start with the concern
An in-person clinic or licensed telehealth service can be a place to discuss your concern. Telehealth means talking with a doctor remotely, rather than in the same room.
Explain the change or problem that prompted the search. Ask for an assessment before narrowing the conversation to a named treatment.
Check who is responsible for the care
As of September 26, 2026, the US health department’s licensing guidance says the person treating you needs permission to practise in your state. That means whichever state you are in at the time of your visit.
Some states let a doctor licensed elsewhere register with their state board for online visits instead of getting a full licence there. The state’s own rules decide whether that is allowed, as of September 26, 2026.
Ask the doctor for their full name and licence or registration details. Have the board for your location at the time of the visit confirm whether that doctor has permission to treat you.
A screen is not a lower care standard
State medical boards are represented by a group called the Federation of State Medical Boards. As of September 17, 2026, it recommends the same standard of care for online visits and visits in person.
These are suggested rules for state boards, rather than a law. Each state sets the rules that doctors must follow.
An assessment does not promise MOTS-c access
MOTS-c remained without US drug approval on September 30, 2026.
Ask how any proposed product would meet the ingredient rules. A doctor’s licence and a product’s status answer separate questions.
Keep this in mind
Choose a route for a real assessment, and bring the product-status question into that visit.
A question to take
Can this doctor assess my concern and discuss options beyond the product I searched for?
Open my notes